FDA approves first drug to slow Alzheimer’s in controversial decision
By
Alicia Lasek
Jun 07, 2021
The evidence convincingly shows that aducanumab (Aduhelm) removes beta amyloid — a hallmark of Alzheimer’s — from the brain, slowing the disease’s progression and giving patients and families much-needed...
Dementia signs, symptoms may be different for Latinos, researchers say
By
Alicia Lasek
May 27, 2021
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
Healthy lifestyle behaviors reduce dementia risk regardless of family history, study finds
By
Donna Shryer
May 21, 2021
Healthy lifestyle behaviors lower dementia risk, and that includes those with or without a family history for dementia, preliminary research from the American Heart Association has found.
Active lifestyle may slow cognitive decline in people with Parkinson’s and dementia gene: study
By
Alicia Lasek
Apr 02, 2021
Greater physical activity at the study’s start appeared to lessen gene-related cognitive decline two years later, the authors report.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
FDA advisers vote ‘no’ on drug that may slow Alzheimer’s progression
By
Alicia Lasek
Nov 09, 2020
If approved by the FDA, aducanumab would be the first-ever drug marketed to slow progression of the brain-wasting disease, according to its developer. But an advisory committee was unconvinced of the drug’s...
Delayed cognitive decline linked to daily use of two languages
By
Alicia Lasek
Sep 21, 2020
People receive a later diagnosis of mild cognitive impairment when they actively speak two languages every day, investigators report.
Clinical briefs for Friday, Sept. 11
By
Kimberly Marselas
Sep 10, 2020
Urinary culture intervention leads to fewer antibiotic prescriptions … Sleep apnea tied to higher spine fracture risk in women … Scientists: Quiet zones in indoor spaces like dining rooms may limit...
Highly accurate Alzheimer’s blood test a ‘breakthrough,’ observers say
By
Alicia Lasek
Jul 30, 2020
The experimental blood test rivals the accuracy of standard diagnostic methods and may soon prove to be a cost-effective, accessible tool in the clinical setting, according to some in the scientific community.